Can You Get Gel Shots in Your Hip? What to Expect

Gel shots, the common name for hyaluronic acid (HA) injections, can be given in the hip and are used by many orthopedic specialists and sports medicine physicians to manage hip osteoarthritis pain. The procedure is less common than gel shots in the knee, and the medical community is genuinely split on whether to recommend them. That split, along with how the injections feel, how long they last, and who stands to benefit most, is worth understanding before you book an appointment.

What Gel Shots Actually Do Inside the Hip

Your hip joint naturally contains synovial fluid rich in hyaluronic acid, a thick substance that lubricates the joint and absorbs shock. As osteoarthritis progresses, the HA in your joint breaks down from a high-molecular-weight form into shorter, lighter chains that do not cushion or lubricate as well. The joint fluid becomes thinner and less protective.

Gel shots aim to supplement that depleted fluid by injecting a manufactured form of HA directly into the joint space. The injected gel does not fully restore everything the original fluid did, but it can relieve pain through several pathways: reducing inflammation, helping the joint retain some of its cushioning properties, and stimulating protective biological activity in the cartilage and surrounding tissue.¹ Think of it less as replacing a worn-out shock absorber and more as adding a better-quality lubricant that also calms down some of the irritation.

Why Guidelines Disagree About Hip Gel Shots

If you research HA injections for the hip, you will quickly run into conflicting recommendations, and that is not because some organizations are out of date. The American College of Rheumatology (ACR) and the Arthritis Foundation conditionally recommend against intra-articular HA for hip and knee osteoarthritis, while the Osteoarthritis Research Society International (OARSI) and the Department of Veterans Affairs/Department of Defense guidelines take a more permissive stance.² A recent review in the Journal of Bone and Joint Surgery summarized the current consensus this way: routine use of HA injections for osteoarthritis is not recommended, but certain patients, particularly those who have tried other treatments without success, may benefit.³

The reason for the split is a persistent question about how much of the benefit comes from the gel itself versus the act of injecting fluid into a painful joint. A systematic review and network meta-analysis of randomized controlled trials found that none of the common hip injections, including HA, corticosteroids, and platelet-rich plasma, showed a significant pain improvement over plain saline injection at two to four months or at six months. All of them, saline included, tended to produce meaningful pain relief compared to no injection at all.⁴ That finding is a major reason the ACR is cautious: if saline does roughly as well, the case for a more expensive HA product weakens.

Yet many individual studies and clinical experiences tell a different story. Numerous publications have favored gel shots for moderate-grade hip osteoarthritis specifically, and a systematic review and meta-analysis concluded that viscosupplementation is the best conservative therapy before surgery for hip disorders, providing real pain relief and functional improvement.⁵ ⁶ In practice, many physicians view the guideline disagreement as a green light to offer gel shots on a case-by-case basis, especially when other non-surgical options have been exhausted.

Who Is Most Likely to Benefit

The evidence suggests that gel shots work best in people with mild to moderate hip osteoarthritis rather than severe, bone-on-bone disease. If you still have some cartilage left and your pain is interfering with daily life but you are not quite ready for a hip replacement, you sit in the sweet spot. Multiple reviews describe this moderate stage of OA as the population most likely to see meaningful relief.⁵

Interestingly, whether your osteoarthritis is “primary” (age-related wear and tear) or “secondary” (caused by an underlying inflammatory condition) also seems to matter. A 2025 study compared the two groups and found that patients with primary osteoarthritis had a substantially larger pain reduction after HA injections, averaging about three points on a standard pain scale, compared to roughly one and a half points in the secondary OA group. Pain scores at follow-up were significantly worse in the secondary group.⁷ If your hip OA stems from an inflammatory condition like rheumatoid arthritis or lupus, gel shots may still help, but your expectations should be calibrated differently than someone with typical wear-and-tear arthritis.

How the Injection Is Done

The hip is a deep joint surrounded by thick muscle, which makes injecting it trickier than injecting a knee. Unlike with knee gel shots, where a doctor can often feel the joint space and inject with just anatomical landmarks, hip injections rely heavily on imaging guidance to make sure the needle actually reaches the joint capsule.

Ultrasound guidance has become the gold standard. A systematic review and meta-analysis found that ultrasound-guided hip injections had a weighted accuracy of 100%, compared to about 72% for injections guided by anatomical landmarks alone.⁸ Another systematic review confirmed this hierarchy, finding individual study accuracy rates of 100% for ultrasound, roughly 85% for fluoroscopy (real-time X-ray), and about 70% for landmark-guided injections.⁹ You should ask your provider what guidance method they use. If they say they inject hips by feel alone, that is a reasonable reason to seek a second opinion or a different provider.

During the procedure, you typically lie on your back or slightly angled. The doctor applies ultrasound gel to the skin over your hip, locates the joint on the screen, numbs the skin with a local anesthetic, and advances the needle into the joint while watching its path on the ultrasound in real time. The whole process usually takes just a few minutes. Some protocols call for a series of three injections given one week apart, while others use a single injection of a higher-density or cross-linked HA product.

What the Experience Feels Like and What Happens After

Most people describe the injection itself as pressure with a brief sting, somewhat more uncomfortable than a flu shot but manageable. The local anesthetic applied before the main injection helps. Some patients feel a fullness or mild ache in the hip afterward as the joint accommodates the new fluid. Minor soreness at the injection site for a day or two is common.

Adverse events are generally mild. In a prospective study of HA combined with a corticosteroid injected into hips with mild to moderate OA, about 5% of patients reported hip pain lasting less than a week, and fewer than 1% had pain lasting up to a month.¹⁰ Serious complications like infection are rare with proper sterile technique. A meta-analysis looking at safety across different HA formulations found that systemic side effects occurred in less than 1% of patients across all groups, and local reactions like temporary swelling or pain occurred in about 10% of patients receiving most formulations.¹¹

You can usually walk out of the office and resume light activities the same day. Most providers recommend avoiding strenuous exercise for 24 to 48 hours. You probably will not notice full pain relief immediately. In studies using a series of three weekly injections, significant improvement in pain during activity and at rest, as well as stiffness and physical function, was measurable about a month after the final injection.¹² How long the benefit lasts varies. Some patients feel relief for three to six months, and some studies have tracked sustained improvement at one year.¹

Does the Type of Gel Matter

Not all HA products are created equal, and the molecular weight of the gel appears to influence both how well it works and how your body reacts. A systematic review and meta-analysis specifically addressing hip osteoarthritis found that high-molecular-weight HA produced the best improvements in pain scores and functional indexes compared to medium-weight and low-weight versions, with significantly better results at three and six months.¹¹

The logic here makes sense when you think about what the gel is replacing. Healthy synovial fluid contains very high-molecular-weight HA, so injecting something closer to that original weight better mimics the joint’s natural cushioning. However, ultra-high-molecular-weight formulations had a noticeably higher local reaction rate (roughly 37% compared to about 10% for the other groups), suggesting there is a ceiling beyond which bigger molecules cause more irritation without added benefit.

Some newer formulations try to get around this tradeoff by combining low and high-molecular-weight HA in one injection. The rationale is that the larger molecules stay in the joint longer and provide better cushioning, while the smaller molecules penetrate deeper into the joint lining to deliver anti-inflammatory and tissue-protective effects.¹³ Your doctor chooses the product based on what is available, what your insurance covers, and clinical judgment about your joint’s condition. It is worth asking which formulation they plan to use and why.

Gel Shots Versus Corticosteroid Injections

Corticosteroid (steroid) injections are the other common hip injection for osteoarthritis, and your doctor may offer you a choice or steer you toward one based on your situation. Steroid shots work differently: they suppress inflammation rapidly and tend to provide faster relief, sometimes within days. HA injections have a slower onset but may last longer. A practical summary from one review noted that corticosteroids are effective for pain relief in hip OA, but repeated injections should be avoided, and there should be an interval of at least three months between a steroid hip injection and any planned hip replacement surgery.⁵

Some providers use a combined approach: one study found that injecting cross-linked HA together with a corticosteroid (triamcinolone) produced significant improvements in pain, function, and quality of life scores from baseline to six months, along with a decrease in the percentage of patients needing daily pain medication.¹⁰ The idea is that the steroid provides quick relief while the gel takes over for longer-term cushioning. Whether this combined approach is truly better than either alone is still being studied, but it is an option you may encounter.

What About Platelet-Rich Plasma

Platelet-rich plasma (PRP) injections have gained attention as a biologic alternative to gel shots. PRP is made from your own blood, processed to concentrate platelets and their growth factors, and then injected into the joint. The appeal is that it theoretically promotes healing rather than just cushioning.

The evidence for the hip so far is mixed. A randomized clinical trial comparing PRP to HA injections in patients with early hip osteoarthritis found that PRP did not offer significantly better results, and the authors concluded it should not be considered a first-line treatment over HA.¹⁴ A separate retrospective study found that both PRP-HA combinations and a leukocyte-and-platelet-rich plasma (L-PRP) formulation reduced pain in the short to medium term, with both reaching maximum pain reduction around three months. L-PRP showed somewhat better pain reduction over time at one year, though neither treatment significantly improved functional scores like the Harris Hip Score.¹⁵

PRP is also typically not covered by insurance, making it a significantly more expensive option. For most patients with hip OA exploring injectable treatments, HA remains the more established and accessible choice.

Can Gel Shots Delay or Prevent a Hip Replacement

This is one of the most common questions people ask after learning about gel shots, and the honest answer is nuanced. HA injections can relieve pain and improve function, and a systematic review described viscosupplementation as the best conservative therapy before surgery for hip disorders.¹⁶ But the same review was clear that there is no evidence HA injections modify the structure of a damaged hip or change the natural course of the disease. They do not regrow cartilage or reverse osteoarthritis.

In practical terms, if gel shots reduce your pain enough that you can stay active, maintain muscle strength, and avoid the limitations that lead someone to pursue surgery, they are effectively buying time. In the study combining HA with a corticosteroid, about 3% of patients ended up having a hip replacement within the study period, meaning the vast majority did not progress to surgery in the short term.¹⁰ But for someone with advanced disease, gel shots are unlikely to serve as a meaningful alternative to replacement. They are better understood as a bridge than a destination.

Gel Shots for Non-Arthritis Hip Problems

While osteoarthritis is the primary reason doctors consider gel shots for the hip, researchers have explored their use in other hip conditions as well. Femoroacetabular impingement, a condition where abnormally shaped hip bones pinch during movement, is one area where early results look promising. A study of patients with mild impingement found that HA injections provided significant pain reduction and functional improvement, and the treatment was considered safe.¹⁷ A broader review also noted encouraging short-term results for HA in impingement cases.¹⁶

For labral tears, the evidence is thinner. A review from the Journal of Hip Preservation Surgery found limited evidence to support routine use of therapeutic injections, whether corticosteroid or HA, for labral tears and femoroacetabular impingement as a group.¹⁸ That does not mean they never help in these situations, but it does mean you should not expect the same level of supporting data that exists for osteoarthritis. If your doctor suggests a gel shot for a non-OA hip condition, it is reasonable to ask what evidence supports that specific use.

Insurance and Access Realities

One of the practical hurdles with hip gel shots is coverage. Because major guidelines like the ACR recommend against HA injections, some insurance plans decline to cover them, particularly for the hip. Medicare’s coverage varies by region and product. Gel shots for the knee have a somewhat more established reimbursement pathway, so if you have had knee gel shots covered previously, do not assume the same policy extends to the hip.

Out-of-pocket costs for a single HA injection session can range from a few hundred to over a thousand dollars depending on the product and provider. Cross-linked and high-molecular-weight products tend to cost more but may require fewer injections (sometimes just one) compared to lower-weight products that are given in a series of three. If cost is a factor, discussing the formulation options with your doctor can help you weigh the tradeoff between upfront expense and the number of office visits needed.

Some patients pursue gel shots at sports medicine clinics or interventional pain practices that specialize in ultrasound-guided procedures. These settings are often well equipped for accurate hip injections and may have more experience with the technique than a general orthopedic office that primarily does surgical cases. Asking how many hip injections a provider performs each month is a perfectly fair question.